Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07442149) titled 'An Investigational Study to Evaluate the Safety and Tolerability of Single and Multiple Ascending Doses of A-005' on Feb. 24.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Sequential Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Investigator, Outcomes Assessor).
Primary Sponsor: Alumis Inc
Condition:
Healthy Volunteer
Intervention:
Drug: A-005
Drug: A-005
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: April 22, 2024
Target Sample Size: 135
Countries of Recruitment:
United States
To know more, visit https://cli...